These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 32381737)

  • 1. Evolving COVID-19 conundrum and its impact.
    Chookajorn T
    Proc Natl Acad Sci U S A; 2020 Jun; 117(23):12520-12521. PubMed ID: 32381737
    [No Abstract]   [Full Text] [Related]  

  • 2. Authors' response: Plenty of coronaviruses but no SARS-CoV-2.
    Reusken CB; Haagmans B; Meijer A; Corman VM; Papa A; Charrel R; Drosten C; Koopmans M
    Euro Surveill; 2020 Feb; 25(8):. PubMed ID: 32127125
    [No Abstract]   [Full Text] [Related]  

  • 3. Asymptomatic coronavirus infection: MERS-CoV and SARS-CoV-2 (COVID-19).
    Al-Tawfiq JA
    Travel Med Infect Dis; 2020; 35():101608. PubMed ID: 32114075
    [No Abstract]   [Full Text] [Related]  

  • 4. Sampling bias and incorrect rooting make phylogenetic network tracing of SARS-COV-2 infections unreliable.
    Mavian C; Pond SK; Marini S; Magalis BR; Vandamme AM; Dellicour S; Scarpino SV; Houldcroft C; Villabona-Arenas J; Paisie TK; Trovão NS; Boucher C; Zhang Y; Scheuermann RH; Gascuel O; Lam TT; Suchard MA; Abecasis A; Wilkinson E; de Oliveira T; Bento AI; Schmidt HA; Martin D; Hadfield J; Faria N; Grubaugh ND; Neher RA; Baele G; Lemey P; Stadler T; Albert J; Crandall KA; Leitner T; Stamatakis A; Prosperi M; Salemi M
    Proc Natl Acad Sci U S A; 2020 Jun; 117(23):12522-12523. PubMed ID: 32381734
    [No Abstract]   [Full Text] [Related]  

  • 5. Median-joining network analysis of SARS-CoV-2 genomes is neither phylogenetic nor evolutionary.
    Sánchez-Pacheco SJ; Kong S; Pulido-Santacruz P; Murphy RW; Kubatko L
    Proc Natl Acad Sci U S A; 2020 Jun; 117(23):12518-12519. PubMed ID: 32381733
    [No Abstract]   [Full Text] [Related]  

  • 6. A cluster of pneumonia associated with the SARS-Cov-2 outside of Wuhan related to a house-warming banquet.
    Liu L; Quan J; Lv J; Long S; Hu W; Zhuge H; Zhou Z; Zhao D
    J Infect; 2020 Jul; 81(1):147-178. PubMed ID: 32283138
    [No Abstract]   [Full Text] [Related]  

  • 7. From SARS-CoV to SARS-CoV-2: The response and challenge of forensic infectious disease autopsy.
    Wang HJ
    Fa Yi Xue Za Zhi; 2020 Feb; 36(1):1-3. PubMed ID: 32198983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges and issues of SARS-CoV-2 pool testing.
    Eberhardt JN; Breuckmann NP; Eberhardt CS
    Lancet Infect Dis; 2020 Nov; 20(11):1233-1234. PubMed ID: 32679088
    [No Abstract]   [Full Text] [Related]  

  • 9. Challenges and issues of SARS-CoV-2 pool testing.
    Mishra B; Behera B; Mohanty M; Ravindra A; Ranjan J
    Lancet Infect Dis; 2020 Nov; 20(11):1233. PubMed ID: 32679083
    [No Abstract]   [Full Text] [Related]  

  • 10. Challenges and issues of SARS-CoV-2 pool testing.
    Lee J; Kim SY; Sung H; Lee SW; Lee H; Roh KH; Yoo CK; Hong KH
    Lancet Infect Dis; 2020 Nov; 20(11):1232-1233. PubMed ID: 32679080
    [No Abstract]   [Full Text] [Related]  

  • 11. Why Does SARS-CoV-2 Invade the Gastrointestinal Epithelium?
    Uno Y
    Gastroenterology; 2020 Oct; 159(4):1622-1623. PubMed ID: 32283099
    [No Abstract]   [Full Text] [Related]  

  • 12. Duration for carrying SARS-CoV-2 in COVID-19 patients.
    Du X; Yu X; Li Q; Li X; Qin T; Luo Q; Wang M; Jiang M; Bai L; Wang X; Pan Y
    J Infect; 2020 Jul; 81(1):e78-e79. PubMed ID: 32283161
    [No Abstract]   [Full Text] [Related]  

  • 13. COVID-19 and cardiovascular disorder.
    Mungmungpuntipantip R; Wiwanitkit V
    Minerva Cardioangiol; 2020 Jun; 68(3):277. PubMed ID: 32319272
    [No Abstract]   [Full Text] [Related]  

  • 14. Duration of SARS-CoV-2 viral RNA in asymptomatic carriers.
    Yan X; Han X; Fan Y; Fang Z; Long D; Zhu Y
    Crit Care; 2020 May; 24(1):245. PubMed ID: 32448332
    [No Abstract]   [Full Text] [Related]  

  • 15. Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19.
    Sharun K; Dhama K; Patel SK; Pathak M; Tiwari R; Singh BR; Sah R; Bonilla-Aldana DK; Rodriguez-Morales AJ; Leblebicioglu H
    Ann Clin Microbiol Antimicrob; 2020 May; 19(1):23. PubMed ID: 32473642
    [No Abstract]   [Full Text] [Related]  

  • 16. Reply to Sánchez-Pacheco et al., Chookajorn, and Mavian et al.: Explaining phylogenetic network analysis of SARS-CoV-2 genomes.
    Forster P; Forster L; Renfrew C; Forster M
    Proc Natl Acad Sci U S A; 2020 Jun; 117(23):12524-12525. PubMed ID: 32439706
    [No Abstract]   [Full Text] [Related]  

  • 17. SARS-CoV, Mers-CoV and COVID-19: what differences from a dermatological viewpoint?
    Rongioletti F
    J Eur Acad Dermatol Venereol; 2020 Oct; 34(10):e581-e582. PubMed ID: 32526085
    [No Abstract]   [Full Text] [Related]  

  • 18. Hospital-at-Home as an Alternative to Release the Overload of Healthcare Systems During the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic.
    Arias-de la Torre J; Alonso J; Martín V; Valderas JM
    J Am Med Dir Assoc; 2020 Jul; 21(7):990-991. PubMed ID: 32499181
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of the hyper-variable genomic hotspot for the novel coronavirus SARS-CoV-2.
    Wen F; Yu H; Guo J; Li Y; Luo K; Huang S
    J Infect; 2020 Jun; 80(6):671-693. PubMed ID: 32145215
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk of SARS-CoV-2 Diffusion when Performing Minimally Invasive Surgery During the COVID-19 Pandemic.
    Novara G; Giannarini G; De Nunzio C; Porpiglia F; Ficarra V
    Eur Urol; 2020 Jul; 78(1):e12-e13. PubMed ID: 32336644
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.